Search results
Leo’s single-dose autoinjector secures FDA approval for atopic dermatitis
Pharmaceutical Technology via Yahoo Finance· 5 days agoLeo Pharma has announced that its injection treatment for atopic dermatitis, Adbry...
Union Therapeutics shares positive data on atopic dermatitis drug trial
Clinical Trials Arena via Yahoo Finance· 6 days agoDenmark-based pharmaceutical company Union Therapeutics has shared data from its ADESOS Phase 2b...
Tapinarof may mark Dermavant’s first atopic dermatitis approval
Clinical Trials Arena via Yahoo Finance· 6 days agoFollowing the recent positive results of the Phase III clinical trial for Dermavant’s VTAMA...
Topical Treatment Effective for Young Kids Up to 52 Weeks
Medscape· 1 day agoNo treatment-related interruptions, discontinuations, or serious adverse events were observed with...
Summer skin safety: UCLA Health pediatric dermatol | Newswise
Newswise· 1 day agoJayden Galamgam, MD, pediatric dermatologist at UCLA Health, treats a variety of pediatric skin...
The 13 Best Deodorants That Won’t Irritate Sensitive Underarms
Elle via AOL· 15 hours agoSince it’s a roll-on formula, it couldn’t be easier to use. Size: 50 mL. Amazon rating: 4.1/5 An...
Uses and Benefits of Colloidal Oatmeal
Health via Yahoo News· 5 days agoThe U.S. Food and Drug Administration (FDA) lists colloidal oatmeal as a skin protectant. The FDA requires that all over-the-counter products that claim...
Sanibel Captiva Trust Company Inc. Invests $41.99 Million in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 4 days agoSanibel Captiva Trust Company Inc. acquired a new position in AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities ...
Enveda Biosciences secures $55m to advance drug discovery
Pharmaceutical Technology via Yahoo Finance· 22 hours agoEnveda anticipates commencing the trials of these programmes in late 2024 and early 2025. The lead...
Regeneron director Brown sells shares worth over $1.5 million By Investing.com
Investing.com· 12 hours agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) Director Michael S. Brown has completed...
